Reducing antibiotic treatment duration for ventilator-associated pneumonia (REGARD-VAP): a trial protocol for a randomised clinical trial

INTRODUCTION: Ventilator-associated pneumonia (VAP) is the most common nosocomial infection in intensive care units (ICUs). Using short-course antibiotics to treat VAP caused by Gram-negative non-fermenting bacteria has been reported to be associated with excess pneumonia recurrences. The “REducinG...

Descripción completa

Detalles Bibliográficos
Autores principales: Mo, Yin, West, Timothy Eoin, MacLaren, Graeme, Booraphun, Suchart, Li, Andrew Yunkai, Kayastha, Gyan, Lau, Yie Hui, Chew, Yin Tze, Chetchotisakd, Ploenchan, Tambyah, Paul Anantharajah, Limmathurotsakul, Direk, Cooper, Ben
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Infectious Diseases
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8126270/
https://www.ncbi.nlm.nih.gov/pubmed/33986070
http://dx.doi.org/10.1136/bmjopen-2021-050105

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8126270/
https://www.ncbi.nlm.nih.gov/pubmed/33986070
http://dx.doi.org/10.1136/bmjopen-2021-050105

Ejemplares similares